title: Calculating occupancy when one does not have baseline: a comparison of different options.
abstract: Dopamine D(2) receptor occupancy of antipsychotic drugs is calculated relative to the subject's D(2) receptor binding potential (BP) in the drug-free state (baseline BP). Because baseline BP is seldom known in patients with schizophrenia, population means from unrelated control samples are often used to estimate it. However, this is likely to introduce bias and error into the occupancy measure. There is thus a need for a method to reliably estimate baseline BP for patient populations in whom it may be impractical or unethical to get baseline measurements. It has been previously found that the relationship between plasma concentration and dopamine receptor occupancy by antipsychotic drugs follows a sigmoid E(max) model. Based on this, we developed a method for calculating dopamine D(2) receptor occupancy by antipsychotic drugs using an inhibitory E(max) model (I(max) method) that estimates individual baseline BPs. To validate this, we compared the result from the I(max) method with actual occupancy and estimated occupancy calculated from the average baseline BP (substitution method). The data for validation were obtained from two different receptor occupancy studies with the antipsychotic medications YKP1358 and aripiprazole. We estimated the reliability between the true measured occupancy and the predicted occupancy using the intraclass correlation coefficient (ICC), and the variability of occupancy was also compared between the I(max) and substitution methods. In YKP1358 study, all the ICCs of the I(max) method were above 0.8, but those of the substitution method showed values lower than 0.8. In aripiprazole study, the ICCs of the I(max) method were higher than those of the substitution method, but all the ICCs showed higher values than 0.8. The variability of I(max) method was significantly smaller than that of substitution method in both studies. The I(max) method shows better reliability and less variability than the substitution method. The I(max) method can be applied for receptor occupancy study, and bring more reliability and accuracy to the occupancy study in patients with schizophrenia.
authors.affiliation: Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea.
authors.forename: Euitae
authors.initials: E
authors.lastname: Kim
authors.forename: Oliver D
authors.initials: OD
authors.lastname: Howes
authors.forename: Kyung-Sang
authors.initials: KS
authors.lastname: Yu
authors.forename: Jae Min
authors.initials: JM
authors.lastname: Jeong
authors.forename: Jae Sung
authors.initials: JS
authors.lastname: Lee
authors.forename: In-Jin
authors.initials: IJ
authors.lastname: Jang
authors.forename: Sang-Goo
authors.initials: SG
authors.lastname: Shin
authors.forename: Shitij
authors.initials: S
authors.lastname: Kapur
authors.forename: Jun Soo
authors.initials: JS
authors.lastname: Kwon
mesh_terms: D000328:Adult; D000470:Alkaloids / Q000097:blood / Q000493:pharmacokinetics; D014150:Antipsychotic Agents / Q000097:blood / Q000493:pharmacokinetics*; D000068180:Aripiprazole; D006801:Humans; D008297:Male; D008722:Methods; D010879:Piperazines / Q000097:blood / Q000493:pharmacokinetics; D049268:Positron-Emission Tomography; D011485:Protein Binding; D015363:Quinolones / Q000097:blood / Q000493:pharmacokinetics; D017448:Receptors, Dopamine D2 / Q000378:metabolism; D015203:Reproducibility of Results; D012559:Schizophrenia / Q000188:drug therapy; D055815:Young Adult
chemical_list: D000470:Alkaloids; D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D017448:Receptors, Dopamine D2; C518965:YKP 1358; D000068180:Aripiprazole